Annual Drug Patent Expirations for ALIMTA Alimta is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. There is one patent protecting…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for PEMFEXY Pemfexy is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are two patents…
PEMFEXY (pemetrexed) Eagle pharms Patent: 7,772,209 Expiration: May 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…
PEMFEXY (pemetrexed) Eagle pharms Patent: 7,772,209 Expiration: May 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation…
Annual Drug Patent Expirations for PROTONIX+IV Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three…
TARGINIQ (naloxone hydrochloride; oxycodone hydrochloride) Purdue pharma lp Patent: 9,511,066 Expiration: May 10, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are thirteen patents protecting this drug. XHANCE drug…
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-one…
